Retention and attrition among African Americans in the STAR*D study: What causes research volunteers to stay or stray?

Depression and Anxiety

Volumn 30, Issue 11, 2013, Pages 1137-1144

  Murphy, Eleanor J ^a   Kassem, Layla ^a   Chemerinski, Anat ^a   Rush, A John ^b   Laje, Gonzalo ^a   McMahon, Francis J ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Blacks; depression; disparities; ethnic groups; research volunteers; Treatment

Indexed keywords

AFRICAN AMERICAN; ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; CAUCASIAN; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; HEALTH DISPARITY; HUMAN; MARRIAGE; MEDICATION COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; RESEARCH SUBJECT; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; VOLUNTEER;

BLACKS; DEPRESSION; DISPARITIES; ETHNIC GROUPS; RESEARCH VOLUNTEERS; TREATMENT;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIDEPRESSIVE AGENTS; CITALOPRAM; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, MAJOR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PATIENT DROPOUTS; PSYCHOTHERAPY; SELF REPORT; TREATMENT OUTCOME; UNITED STATES;

EID: 84887260195     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22134     Document Type: Article

References (35)

1. Lesser IM, Zisook S, Gaynes BN, et al. Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial. Psychiatr Serv 2011; 62: 1167-1179.
2. Warden D, Rush AJ, Wisniewski SR, et al. Income and attrition in the treatment of depression: a STAR*D report. Depress Anxiety 2009; 26 (7): 622-633.
3. Warden D, Trivedi MH, Wisniewski SR, et al. Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry 2007; 164: 1189-1197. (Pubitemid 47292407)
4. Lesser IM, Castro DB, Gaynes BN, et al. Ethnicity/race and outcome in the treatment of depression: results from STAR*D. Med Care 2007; 45 (11): 1043-1051.
5. Diaz E, Woods SW, Rosenheck RA,. Effects of ethnicity on psychotropic medications adherence. Community Ment Health J 2005; 41 (5): 521-537. (Pubitemid 41243115)
6. Fortuna LR, Alegria M, Gao S,. Retention in depression treatment among ethnic and racial minority groups in the United States. Depress Anxiety 2010; 27 (5): 485-494.
7. Dixon L, Lewis-Fernandez R, Goldman H, Interian A, Michaels A, Kiley MC,. Adherence disparities in mental health: opportunities and challenges. J Nerv Ment Dis 2011; 199 (10): 815-820.
8. Anglin DM, Alberti PM, Link BG, Phelan JC,. Racial differences in beliefs about the effectiveness and necessity of mental health treatment. Am J Community Psychol 2008; 42 (1-2): 17-24.
9. Aikens JE, Nease DE, Jr., Klinkman MS,. Explaining patients' beliefs about the necessity and harmfulness of antidepressants. Ann Fam Med 2008; 6 (1): 23-29.
10. Schnittker J, Freese J, Powell B,. Nature, nurture, neither, nor: Black-white differences in beliefs about the causes and appropriate treatment of mental illness. Soc Forces 2000; 78 (3): 1101-1132.
11. Givens JL, Houston TK, Van Voorhees BW, Ford DE, Cooper LA,. Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry 2007; 29 (3): 182-191. (Pubitemid 46680533)
12. Schnittker J,. Misgivings of medicine?: African Americans' skepticism of psychiatric medication. J Health Soc Behav 2003; 44 (4): 506-524. (Pubitemid 38497206)
13. Gonzalez HM, Croghan T, West B, et al. Antidepressant use in black and white populations in the United States. Psychiatr Serv 2008; 59 (10): 1131-1138.
14. Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR,. Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med 2003; 139 (11): 907-915.
15. Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, et al. Race, gender, and partnership in the patient-physician relationship. JAMA 1999; 282 (6): 583-589. (Pubitemid 29380298)
16. Olfson M, Cherry DK, Lewis-Fernandez R,. Racial differences in visit duration of outpatient psychiatric visits. Arch Gen Psychiatry 2009; 66 (2): 214-21.
17. Rush AJ, Fava M, Wisniewski SR, et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials 2004; 25 (1): 119-142. (Pubitemid 38230109)
18. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163 (1): 28-40. (Pubitemid 43050100)
19. Warden D, Rush AJ, Wisniewski SR, et al. What predicts attrition in second step medication treatments for depression?: a STAR*D Report. Int J Neuropsychopharmacol 2009; 12 (4): 459-473.
20. Schraufnagel TJ, Wagner AW, Miranda J, Roy-Byrne PP,. Treating minority patients with depression and anxiety: what does the evidence tell us? Gen Hosp Psychiatry 2006; 28 (1): 27-36. (Pubitemid 41827565)
21. Zimmerman M, Mattia JL,. The reliability and validity of a screening questionnaire for 13 DSM-IV Axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients. J Clin Psychiatry 1999; 60 (10): 677-683. (Pubitemid 29503648)
22. Linn BS, Linn MW, Gurel L,. Cumulative illness rating scale. J Am Geriatr Soc 1968; 16 (5): 622-626.
23. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatr Res 1992; 41 (3): 237-248.
24. Hamilton M,. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
25. Hamilton M,. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6 (4): 278-296.
26. Williams JB,. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiat 1988; 45 (8): 742-747.
27. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C) and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54 (5): 573-583. (Pubitemid 37289444)
28. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA,. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatric Prac 2006; 12 (2): 71-79. (Pubitemid 44284089)
29. Mundt JC, Marks IM, Shear MK, Greist JH,. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry 2002; 180: 461-464. (Pubitemid 34499343)
30. Endicott J, Nee J, Harrison W,. Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993; 29 (2): 321-326. (Pubitemid 23311543)
31. Ware JE, Jr., Sherbourne CD,. The MOS 36 short form health survey (SF 36). I. Conceptual framework and item selection. Med Care 1992; 30 (6): 473-483.
32. Lantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen J,. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA 1998; 279 (21): 1703-1708. (Pubitemid 28247300)
33. Last CG, Thase ME, Hersen M, Bellack AS, Himmelhoch JM,. Patterns of attrition for psychosocial and pharmacologic treatments of depression. J Clin Psychiatry 1985; 46 (9): 361-366. (Pubitemid 15226963)
34. Harman JS, Edlund MJ, Fortney JC,. Disparities in the adequacy of depression treatment in the United States. Psychiat Serv 2004; 55 (12): 1379-1385. (Pubitemid 39577973)
35. Belsher, G, Costello, CG,. Relapse after recovery from unipolar depression: a critical review. Psychol Bull 1988; 104 (1): 84-96.